Indoco
Pramod Ghorpade is an experienced finance professional who currently holds the position of Executive Vice President and CFO at Indoco Remedies Limited. Pramod has a strong background in financial management, having served in various senior roles such as Country CFO at Watson Pharma Private Limited and General Manager Finance at Watson Pharma Pvt Ltd. Pramod has extensive experience in financial reporting, budgeting, taxation, and compliance. Pramod is a Chartered Accountant with a degree from The Institute of Chartered Accountants of India.
Indoco
Indoco Remedies Limited is an India-based company, which is engaged in the manufacture of pharmaceutical products. The Company primarily manufactures and markets Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). The Company's geographical segments include India and Outside India. It offers products for various therapeutic categories, such as stomatologicals, respiratory, anti-infectives, gastrointestinal, pain/analgesics, gynecological, vitamins/minerals/nutrients, ophthal/otologicals and dermatology. Its domestic marketing divisions include INDOCO, SPADE, Warren NxGen, Warren Ace, Spera, Indoco Focus, Indoco CND, Warren Excel, Warren Vision, Eterna, Institution and Indoco IMPULSE. The Company's products include Sensodent-K, Homide, Carmicide, Renolen, Rexidin M, Febrex Plus, Zincoren, Otorex, Cloben G, Methycal, Tuspel, Scabex, Hemsyl, Karvol Plus, Durashape, Lignox, Sensoform Toothpaste, Kidodent Toothpaste, Rosuchek D, Otichek and Irimist.